NasdaqGM:VCYTBiotechs
Veracyte (VCYT) On Pipeline Momentum And A Valuation Question
Veracyte (VCYT) has drawn investor attention after recent share price moves, with the stock up over the past week, month and past 3 months, prompting closer scrutiny of its current valuation.
See our latest analysis for Veracyte.
At a share price of $60.49, Veracyte has seen strong short term momentum, with a 30 day share price return of 35.96% and a 90 day share price return of 101.57%, alongside a 1 year total shareholder return of 120.93%. Together, these figures point to a stock where...